Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
BA2869 VII-31Summary: VII-31 is a NEDDylation pathway activator that inhibits tumors in vitro and in vivo. -
BA2904 RO8994Summary: A potent and selective MDM2 inhibitor with IC50 of nM (HTRF binding assay) and 20 nM (MTT proliferation assay). -
BA2912 PhenoxodiolSummary: Phenoxodiol (Idronoxil) is a synthetic analog of Genestein that activates the mitochondrial system, inhibits (an apoptosis inhibitor), and sensitizes cancer cells to Fas-mediated apoptosis. -
BA8685 PhellopterinSummary: Phellopterin is a natural product. -
C8937 AK-1690Summary: A selective PROTAC degrader targeting STAT6 -
C8995 CB-5339Summary: CB-5339 is a potent, selective p97/VCP ATPase inhibitor targeting protein homeostasis pathways, widely utilized in mechanistic oncology and cellular stress-response research. -
C9056 SubasumstatSummary: A chemical biology tool that selectively inhibits SUMO E1, used for studies of protein SUMOylation. -
C9076 SKPin C1Summary: A selective Skp2-inhibiting small-molecule research tool for studies of the cell cycle and protein homeostasis.
